共 10 条
[1]
HMGCoAreductaseinhibitorsaf fectthefibrinolyticsystemofhumanvascularcellsinvitro:acomparative studyusingdifferentstatins. WiesbauerF,KaunC,ZornG,etal. British Journal of Pharmacology . 2002
[2]
Physiologicalroleofadiposetissue:whiteadipose tissueasanendocrineandsecretory. TrayhurnP,BeattieJH. ProcNutrSoc . 2001
[3]
TheeffectofstatinsonmRNA levelsofgenesrelatedtoinflammation,coagulation,andvascularconstric tioninHUVEC. MorikawaS,TakabeW,MatakiC,etal. JAtherosclerThromb . 2002
[4]
Simvastatinsuppressestissue factorandincreasesfibrinolyticactivityintumornecrosisfactor alpha activat edhumanperitonealmesothelialcells. HaslingerB,KleemannR,ToetKH,etal. Kidney International . 2003
[5]
Pravastatin:anantithrombotic effectindependentofthecholesterol loweringeffect. DangasG,SmithDA,UngerAH,etal. Thrombosis and Haemostasis . 2000
[6]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[7]
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[8]
Effectofadvancedglycationend product modifiedalbuminontissuefactorexpressionbymonocytes. KhechaiF,OllivierF,BrideyM,etal. Arte riosclerThrombVascBiol . 1997
[9]
Angiotensinanditsmetabolitesstimulate PAI1proteinreleasefromhumanadipocytesinprimaryculture. SkurkT,LeeYM,HaunerH. Journal of Hypertension . 2001
[10]
Statinpreventstissuefactorexpres sioninhumanendothelialcells. EtoM,KozaiT,CosentinoF,etal. Circulation . 2002